Skip to main content

1 Result(s)

within Matthew Abbinanti Remove this filter

and

  1. No Access

    Article

    A Brain-Targeted Orally Available ROCK2 Inhibitor Benefits Mild and Aggressive Cavernous Angioma Disease

    Cavernous angioma (CA) is a vascular pathology caused by loss of function in one of the 3 CA genes (CCM1, CCM2, and CCM3) that result in rho kinase (ROCK) activation. We investigated a novel ROCK2 selective inhib...

    Lisa McKerracher, Robert Shenkar, Matthew Abbinanti… in Translational Stroke Research (2020)